Gilead Sciences, Inc.
- SEC CIK
- 0000882095
- Latest filing
- Aug 3, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 13, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 14
- −2 vs. Q4 2024
- Portfolio value
- $1.18B
- −$369.8M (−23.8%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ACLXArcellx, Inc. | COMMON STOCK | 6,720,803 | $440.9M | 37.3% | 00.0% | Unchanged | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 16,707,477 | $419.4M | 35.5% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 31,424,760 | $246.7M | 20.9% | +1,363,636+4.5% | Added | History |
| ASMBAssembly Biosciences, Inc. | COM NEW | 2,209,471 | $21.1M | 1.8% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 452,527 | $19.0M | 1.6% | 00.0% | Unchanged | History |
| KYTXKyverna Therapeutics, Inc. | COM | 4,126,119 | $7.96M | 0.7% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 4,854,443 | $6.65M | 0.6% | 00.0% | Unchanged | History |
| XLOXilio Therapeutics, Inc. | COM | 9,105,451 | $6.60M | 0.6% | 00.0% | Unchanged | History |
| KLRSKalaris Therapeutics, Inc. | COM | 723,273 | $5.81M | 0.5% | 00.0% | UnchangedConverted for a 1-for-23 split | History |
| HOOKHOOKIPA Pharma Inc. | COM | 1,875,945 | $2.03M | 0.2% | 00.0% | Unchanged | History |
| ALLOAllogene Therapeutics, Inc. | COM | 1,156,689 | $1.69M | 0.1% | 00.0% | Unchanged | History |
| CYPHCypherpunk Technologies Inc. | COM NEW | 5,319,148 | $1.62M | 0.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 1,159,145 | $1.48M | 0.1% | −849,193−42.3% | Reduced | History |
| BRNSBarinthus Biotherapeutics plc. | ADS | 369,855 | $359.8K | <0.1% | −250,496−40.4% | Reduced | History |
Sold out since Q4 2024 (2)
Positions held at the end of Q4 2024 that are gone from this filing.